Oova was founded by Amy Divaraniya, Aparna (Amy) Divaraniya, PhD.

Who are Oova's investors?

Oova's investors include BBG Ventures, Connecticut Innovations, Helm, Kluz Ventures, Samsung Next, Spero Ventures, For Good Ventures.

How much funding has Oova raised?

Oova has disclosed $10.3M raised across 1 of its 2 known rounds.

Oova

7 known investors

Find your way into Oova

Paths you didn't know you had: your email and LinkedIn already hold routes to the Oova team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Oova offers a clinical-grade at-home hormone test that pairs with an AI-powered app to measure LH, estrogen (E3G), and progesterone (PdG) levels from urine, scanned via a smartphone camera. It serves women tracking fertility, conception, and perimenopause, providing daily lab-accurate hormone insights that can be shared with their doctors.

AI & Machine Learning Digital Health FemTech

Founders & leadership

Amy Divaraniya FounderAmy Divaraniya holds a PhD in Genetics and Genomics Sciences from Icahn School of Medicine at Mount Sinai and has worked in biotechnology, with expertise in biomarkers and team building. She founded Oova, which develops an at-home hormone test paired with an AI app to measure fertility and menopause-related hormones from urine samples.

Aparna (Amy) Divaraniya, PhD FounderAparna Divaraniya holds a PhD in Genetics and Genomics Sciences from Icahn School of Medicine at Mount Sinai and has worked in biotechnology, including roles in biomarkers and oncology. She founded Oova, which offers a clinical-grade at-home hormone test paired with an AI app to measure LH, estrogen, and progesterone levels from urine samples for women tracking fertility and health.

Investors · 7

BBG Ventureslisted by BBG VenturesNew York · $350K – $1.5M

How we know: BBG Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

Connecticut Innovationslisted by Connecticut InnovationsNew Haven · $500K – $2M

How we know: Connecticut Innovations's portfolio page · Not right? Tell us

Helmlisted by HelmNew York City · $500K

How we know: Helm's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Kluz Ventureslisted by Kluz VenturesWashington

Samsung Nextlisted by Samsung NextMountain View · $100K – $5M

How we know: Samsung Next's portfolio page · Not right? Tell us

Spero Ventureslisted by Spero VenturesBurlingame · $2M – $4M

How we know: funding news · Not right? Tell us

For Good Venturesreported

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Funding

SEC filings, press & company announcements

$10.3M disclosed across 1 of 2 rounds · 2021–2023

$10.3MSeries AJun 2023 · 3 sources
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 5

Flo HealthFlo is a women's health app offering personalized cycle tracking, fertility guidance, pregnancy support, and health education backed by a medical team. The app serves women and people with periods globally with science-based insights on hormonal health from first period to perimenopause.

Natural CyclesNatural Cycles offers an FDA-cleared mobile app that uses a user's body temperature data and an algorithm to predict fertile windows for hormone-free birth control and pregnancy planning. The app supports women's health across life stages from contraception through perimenopause and is certified in over 35 countries.

InitoInito provides fertility and reproductive health services, advised by reproductive endocrinologists and infertility specialists.

ClueClue is a menstrual and reproductive health app that lets people track their periods, cycle, ovulation, fertility, and related symptoms, and contributes anonymized data to scientific research with institutions such as Johns Hopkins and the Gates Foundation. The company offers a paid Clue Plus subscription and serves over 12 million users worldwide.

ProovProov offers at-home hormone and fertility testing products, including systems to identify the fertile window, confirm ovulation, and screen for leading causes of infertility, paired with an app providing hormone insights and personalized recommendations. It serves women tracking their fertility and reproductive wellness.

Companies working in the same space as Oova.

In the news

Oova raises $1.2M to develop a better at-home kit for detecting a woman’s best time to conceive | TechCrunchtechcrunch.com · Jul 2021

Frequently asked questions

What does Oova do?: Oova offers a clinical-grade at-home hormone test that pairs with an AI-powered app to measure LH, estrogen (E3G), and progesterone (PdG) levels from urine, scanned via a smartphone camera. It serves women tracking fertility, conception, and perimenopause, providing daily lab-accurate hormone insights that can be shared with their doctors.
Who founded Oova?: Oova was founded by Amy Divaraniya, Aparna (Amy) Divaraniya, PhD.
Who are Oova's investors?: Oova's investors include BBG Ventures, Connecticut Innovations, Helm, Kluz Ventures, Samsung Next, Spero Ventures, For Good Ventures.
How much funding has Oova raised?: Oova has disclosed $10.3M raised across 1 of its 2 known rounds.